Effect of GLP-1 on Insulin Biosynthesis and Turnover Rates

Effect of GLP-1 on Insulin Biosynthesis and Turnover Rates

Conditions: Type 2 Diabetes
Interventions: Drug: glucagon like peptide-1; Dietary Supplement: glucose control
Sponsors: Albert Einstein College of Medicine; Merck Sharp & Dohme LLC; National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Terminated

Source: View full study details on ClinicalTrials.gov

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. By listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.

February 29, 2024Comments OffClinicalTrials.gov | Endocrinology Clinical Trials | Endocrinology Studies | US National Library of Medicine
Comments